EPIS Revenue and Competitors
Estimated Revenue & Valuation
- EPIS's estimated annual revenue is currently $759k per year.
- EPIS's estimated revenue per employee is $50,600
- EPIS's total funding is $2.7M.
Employee Data
- EPIS has 15 Employees.
- EPIS grew their employee count by 0% last year.
EPIS's People
| Name | Title | Email/Phone |
|---|
EPIS Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $991.5M | 3219 | 9% | N/A | N/A |
#2 | $37.8M | 156 | 4% | N/A | N/A |
#3 | $0.8M | 15 | 0% | $2.7M | N/A |
#4 | $11.1M | 56 | 10% | N/A | N/A |
#5 | $1440M | 3081 | N/A | N/A | N/A |
#6 | $6.7M | 38 | 12% | N/A | N/A |
#7 | $10.9M | 55 | -2% | N/A | N/A |
#8 | $6.9M | 39 | 77% | N/A | N/A |
#9 | $6M | 34 | 70% | N/A | N/A |
What Is EPIS?
EPIS, Inc. is the developer of the AURORAÔ Electric Market Model, the proven leading-edge software package with ready-to-use data for all the reliability regions in North America to forecast wholesale electricity market prices. Leading energy providers, power-marketing companies, energy consultants, and utilities use AURORA to model wholesale electricity prices and perform various long-range planning and risk analysis studies.
keywords:N/A
$2.7M
Total Funding
15
Number of Employees
$759k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
EPIS News
COVID-19 Weekly EPI Report - New COVID-19 Treatment Available. Released on April 21, 2022. The oral antiviral Paxlovid continues to be available by...
It looks like Epiroc AB (publ) (STO:EPI A) is about to go ex-dividend in the next 3 days. The ex-dividend date occurs one day before the...
Here, the epis is used as both salsa and a marinade for the fish. Traditional pikliz calls for sour oranges and scotch bonnet peppers, but if...
Other Companies in Sandpoint
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.8M | 23 | -12% | N/A |
#2 | $8.5M | 34 | 3% | N/A |
#3 | $1.7M | 38 | 0% | N/A |
#4 | $7.5M | 38 | 3% | N/A |
#5 | $3.5M | 39 | 11% | N/A |